APLASTIC ANEMIA
Clinical trials for APLASTIC ANEMIA explained in plain language.
Never miss a new study
Get alerted when new APLASTIC ANEMIA trials appear
Sign up with your email to follow new studies for APLASTIC ANEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for anemia patients in groundbreaking bone marrow trial
Disease control CompletedThis study tested whether adding a new drug called luspatercept to standard treatment could better improve blood cell counts in adults with a specific, non-severe form of aplastic anemia. Aplastic anemia is a rare condition where the bone marrow fails to make enough blood cells. …
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Bing Han • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New hope for treatment-resistant blood disease patients
Disease control CompletedThis study tested whether the medication eltrombopag could help Chinese adults with severe aplastic anemia, a serious condition where the bone marrow stops making enough blood cells. The trial included 20 patients whose disease had returned or hadn't responded to previous treatme…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Doctors look back at treatment for rare childhood blood disorder
Disease control CompletedThis study looked back at medical records to see how safe and effective a drug called eltrombopag was when used with standard therapy in Korean children with severe aplastic anemia. It involved 13 children who were newly diagnosed and followed their progress over 6 months. The go…
Matched conditions: APLASTIC ANEMIA
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
One donor, two transplants: experimental procedure aims to cure blood cancer and fix kidneys
Disease control CompletedThis pilot study tested a combined transplant from a partially matched family donor. It aimed to treat patients who had both a serious blood disorder (like leukemia) and advanced kidney disease at the same time. The goal was to cure the blood disorder and restore kidney function …
Matched conditions: APLASTIC ANEMIA
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
New drug protocol tested for rare bone marrow disease
Disease control CompletedThis study tested a specific combination of three drugs to treat severe aplastic anemia, a rare condition where the bone marrow stops making enough blood cells. The treatment was given to 40 newly diagnosed patients who were not candidates for a bone marrow transplant. Researcher…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Gentler transplant strategy tested for tough blood cancers
Disease control CompletedThis study tested a two-step, lower-intensity stem cell transplant for patients with high-risk blood cancers like leukemia and lymphoma. The goal was to use milder chemotherapy and radiation before the transplant to reduce side effects while still allowing the donor's immune cell…
Matched conditions: APLASTIC ANEMIA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University • Aim: Disease control
Last updated Mar 02, 2026 15:26 UTC